IL-33 Signaling in Lung Injury

  • et al.
N/ACitations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Interleukin (IL)-33, a member of the IL-1 cytokine super-family, acts as both a traditional cytokine and an intracellular nuclear factor. It is generally released from damaged immune cells and signals through its receptor ST2 in an autocrine and paracrine fashion, plays important roles in type-2 innate immunity, and functions as an "alarmin" or a danger signal for cellular damage or cellular stress. Here, we review recent advances of the role of IL-33 in lung injury and explore its potential significance as an attractive therapeutic target.

Cite

CITATION STYLE

APA

Jing, C., Yue-Feng, X., Ma-Zhong, Z., & Li-Ming, Z. (2016). IL-33 Signaling in Lung Injury. Translational Perioperative and Pain Medicine, 3(2). https://doi.org/10.31480/2330-4871/037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free